Larimar Therapeutics, Inc. (LRMR) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 204.98M | 142.02M | 183.22M | 145.56M | 165.49M | 195.3M | 213.26M | 231.13M | 230.95M | 90.17M | 98.48M | 106.48M |
| Cash & Short-Term Investments | 200.38M | 136.85M | 175.44M | 138.52M | 157.53M | 183.45M | 203.71M | 226.06M | 227.3M | 86.79M | 95.59M | 104.2M |
| Cash Only | 177.91M | 85.41M | 90.14M | 20.59M | 21.13M | 33.22M | 35.07M | 32.31M | 110.13M | 26.75M | 38.72M | 94.32M |
| Short-Term Investments | 22.47M | 51.44M | 85.3M | 117.94M | 136.4M | 150.24M | 168.64M | 193.75M | 117.17M | 60.04M | 56.87M | 9.88M |
| Accounts Receivable | 0 | 747K | 0 | 983K | 1.06M | 1.05M | 943K | 751K | 1.08M | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 4.59M | 4.42M | 1M | 322K | 6.9M | 517K | 371K | 309K | 344K | 0 | 582K | 486K |
| Total Non-Current Assets | 3.53M | 3.82M | 4.13M | 4.43M | 4.69M | 4.92M | 5.76M | 6.03M | 17.25M | 5.76M | 5.47M | 5.24M |
| Property, Plant & Equipment | 2.42M | 2.69M | 2.98M | 3.27M | 3.5M | 3.72M | 3.81M | 4.06M | 3.52M | 3.76M | 3.5M | 3.25M |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 1.34M | 0 | 13.05M | 1.34M | 0 | 0 |
| Other Non-Current Assets | 1.11M | 1.13M | 1.15M | 1.17M | 1.19M | 1.2M | 621K | 1.98M | 678K | 659K | 1.97M | 1.98M |
| Total Assets | 208.51M | 145.84M | 187.35M | 149.99M | 170.18M | 200.22M | 219.02M | 237.16M | 248.21M | 95.94M | 103.95M | 111.72M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | 22.53% | -27.16% | -14.46% | -36.76% | -31.44% | 108.71% | 110.69% | 112.29% | 108.74% | -24.11% | -21.85% | 77.74% |
| Total Current Liabilities | 47.76M | 64.8M | 45.12M | 26.65M | 22.13M | 24.36M | 16.29M | 21.16M | 12.84M | 9.51M | 6.56M | 7.28M |
| Accounts Payable | 8.58M | 5.22M | 11.1M | 4.17M | 2.27M | 2.42M | 1.69M | 2.92M | 1.92M | 1.28M | 756K | 2.34M |
| Days Payables Outstanding | - | - | - | - | - | - | - | - | 1.82K | 1.16K | - | - |
| Short-Term Debt | 1.06M | 1.1M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 38.12M | 58.47M | 0 | 0 | 18.76M | 17.62M | 11.2M | 0 | 9.31M | 5.02M | 0 | 0 |
| Current Ratio | 4.29x | 2.19x | 4.06x | 5.46x | 7.48x | 8.02x | 13.10x | 10.93x | 17.99x | 9.49x | 15.02x | 14.64x |
| Quick Ratio | 4.29x | 2.19x | 4.06x | 5.46x | 7.48x | 8.02x | 13.10x | 10.93x | 17.99x | 9.49x | 15.02x | 14.64x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 2.72M | 2.96M | 3.2M | 3.48M | 3.77M | 4.06M | 4.34M | 4.6M | 4.52M | 4.71M | 4.68M | 4.51M |
| Long-Term Debt | 2.72M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 2.96M | 3.2M | 3.48M | 3.77M | 4.06M | 4.34M | 4.6M | 4.52M | 4.71M | 4.68M | 4.51M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 50.48M | 67.76M | 48.31M | 30.13M | 25.9M | 28.41M | 20.62M | 25.76M | 17.36M | 14.21M | 11.24M | 11.79M |
| Total Debt | 3.78M | 4.07M | 4.35M | 4.61M | 4.87M | 5.12M | 5.36M | 5.59M | 5.34M | 5.55M | 5.39M | 5.08M |
| Net Debt | -174.13M | -81.34M | -85.79M | -15.97M | -16.26M | -28.1M | -29.7M | -26.72M | -104.78M | -21.2M | -33.33M | -89.24M |
| Debt / Equity | 0.02x | 0.05x | 0.03x | 0.04x | 0.03x | 0.03x | 0.03x | 0.03x | 0.02x | 0.07x | 0.06x | 0.05x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 158.03M | 78.08M | 139.04M | 119.85M | 144.27M | 171.81M | 198.4M | 211.4M | 230.84M | 81.72M | 92.71M | 99.93M |
| Equity Growth % | 9.54% | -54.55% | -29.92% | -43.31% | -37.5% | 110.24% | 114% | 111.55% | 117.28% | -26.31% | -21.87% | 99.64% |
| Book Value per Share | 1.86 | 0.92 | 1.78 | 1.87 | 2.26 | 2.69 | 3.11 | 3.31 | 4.31 | 1.86 | 2.11 | 2.28 |
| Total Shareholders' Equity | 158.03M | 78.08M | 139.04M | 119.85M | 144.27M | 171.81M | 198.4M | 211.4M | 230.84M | 81.72M | 92.71M | 99.93M |
| Common Stock | 103K | 83K | 86K | 64K | 64K | 64K | 64K | 64K | 64K | 43K | 43K | 43K |
| Retained Earnings | -464.44M | -434.83M | -372.33M | -324.62M | -298.44M | -269.16M | -240.33M | -224.84M | -203.21M | -188.55M | -175.56M | -166.5M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 54K | 66K | -9K | 54K | 148K | 358K | -150K | -25K | 81K | 7K | 12K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |